These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 17164111)

  • 1. Biological characteristics of cancers in the gallbladder and biliary tract and targeted therapy.
    Thomas MB
    Crit Rev Oncol Hematol; 2007 Jan; 61(1):44-51. PubMed ID: 17164111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted therapies for cancer of the gallbladder.
    Thomas MB
    Curr Opin Gastroenterol; 2008 May; 24(3):372-6. PubMed ID: 18408467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
    Furuse J; Okusaka T; Ohkawa S; Nagase M; Funakoshi A; Boku N; Yamao K; Yamaguchi T; Sato T
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):113-20. PubMed ID: 19404641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Survival benefits of chemotherapy for unresectable biliary tract cancer--a multicenter retrospective analysis].
    Funakoshi A; Horiuchi H; Sakai T; Miyahara T; Muranaka T; Nakamura M; Mizumoto K; Ueki T; Taketomi A; Yamaguchi H; Sumii T; Ito T
    Gan To Kagaku Ryoho; 2010 Dec; 37(13):2875-9. PubMed ID: 21160263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chemotherapy in cancers of the gallbladder and bile ducts].
    Okada S; Okazaki N
    Gan To Kagaku Ryoho; 1991 Jul; 18(8):1269-72. PubMed ID: 2069397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gallbladder and biliary tract carcinoma: A comprehensive update, Part 1.
    Rajagopalan V; Daines WP; Grossbard ML; Kozuch P
    Oncology (Williston Park); 2004 Jun; 18(7):889-96. PubMed ID: 15255172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gallbladder and biliary tract carcinoma: A comprehensive update, Part 2.
    Daines WP; Rajagopalan V; Grossbard ML; Kozuch P
    Oncology (Williston Park); 2004 Jul; 18(8):1049-59; discussion 1060, 1065-6, 1068. PubMed ID: 15328897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Descriptive study of gallbladder, extrahepatic bile duct, and ampullary cancers in the United States, 1997-2002.
    Goodman MT; Yamamoto J
    Cancer Causes Control; 2007 May; 18(4):415-22. PubMed ID: 17264972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial Risk of Biliary Tract Cancers: A Population-Based Study in Utah.
    Samadder NJ; Smith KR; Wong J; Hanson H; Boucher K; Burt RW; Charlton M; Byrne KR; Gallegos-Orozco JF; Koptiuch C; Curtin K
    Dig Dis Sci; 2016 Dec; 61(12):3627-3632. PubMed ID: 27655103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging treatment with systemic chemotherapy and targeted agents for biliary cancers.
    Boku N
    Curr Opin Investig Drugs; 2010 Jun; 11(6):653-60. PubMed ID: 20496260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymidylate synthase and dihydropyrimidine dehydrogenase are upregulated in pancreatic and biliary tract cancers.
    Shimoda M; Sawada T; Kubota K
    Pathobiology; 2009; 76(4):193-8. PubMed ID: 19571608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Management of biliary tract carcinomas].
    Delbaldo C; Laurent A; Grenier J; Cherqui D; Luciani A; Piedbois P
    Rev Prat; 2009 Apr; 59(4):469-73. PubMed ID: 19462864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biliary Tract Cancer: Epidemiology, Radiotherapy, and Molecular Profiling.
    Bridgewater JA; Goodman KA; Kalyan A; Mulcahy MF
    Am Soc Clin Oncol Educ Book; 2016; 35():e194-203. PubMed ID: 27249723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted therapy in biliary tract cancer: 2009 update.
    Tonini G; Virzì V; Fratto ME; Vincenzi B; Santini D
    Future Oncol; 2009 Dec; 5(10):1675-84. PubMed ID: 20001803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic and targeted therapy for biliary tract tumors and primary liver tumors.
    Thomas MB
    Surg Oncol Clin N Am; 2014 Apr; 23(2):369-81. PubMed ID: 24560115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biliary tract cancers: molecular profiling as a tool for treatment decisions. A literature review.
    Berardi R; Scartozzi M; Freddari F; Squadroni M; Santinelli A; Bearzi I; Fabris G; Cascinu S
    Cancer Treat Rev; 2006 Aug; 32(5):333-47. PubMed ID: 16762510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geographical distribution of biliary tract cancer in Niigata prefecture.
    Kato K; Akai S
    Jpn J Clin Oncol; 1990 Mar; 20(1):67-71. PubMed ID: 2319700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward personalized treatment of advanced biliary tract cancers.
    Geynisman DM; Catenacci DV
    Discov Med; 2012 Jul; 14(74):41-57. PubMed ID: 22846202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biliary tract cancer incidence and trends in the United States by demographic group, 1999-2013.
    Van Dyke AL; Shiels MS; Jones GS; Pfeiffer RM; Petrick JL; Beebe-Dimmer JL; Koshiol J
    Cancer; 2019 May; 125(9):1489-1498. PubMed ID: 30645774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The epidemiological trends of biliary tract cancers in the United States of America.
    Jiang Y; Jiang L; Li F; Li Q; Yuan S; Huang S; Fu Y; Yan X; Chen J; Li H; Li S; Liu J
    BMC Gastroenterol; 2022 Dec; 22(1):546. PubMed ID: 36581813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.